Ontario Molecular Pathology Research Network

OMPRN is a province-wide network of pathologists, clinical laboratory scientists and cancer researchers collaborating to carry out high-quality cancer research with a clear potential for clinical impact.

We’re Passionate about Pathology

The mission of OMPRN is to enhance molecular pathology research capacity across Ontario through providing research project support, education and networking opportunities for pathologists, clinical laboratory scientists and cancer researchers wishing to improve their skills in molecular aspects of cancer.

Learn More

$4.6M

Awarded to pathology-led research projects since 2016

Research projects funded

Principal investigators funded across Ontario

Pathology trainees involved in research projects

Recent News

July, 2026 – Letter from the OMPRN Director

By Harriet Feilotter Don’t take too long to notice that summer has arrived- it won’t last forever! I hope that all of our OM…

July, 2026 – Building trust in cancer education

By Leigh-Ann van Strijp Whether someone is navigating a cancer diagnosis or they just want to find out about advances in cancer re…

July, 2026 – A microdose of survey data from our microlesson study

By Kyster Nanan Many of you will recall that, earlier this year, OMPRN launched a study to test whether our plain-language molecul…

December, 2025 – Letter from the OMPRN Director

As 2025 draws to a close, it feels like the right time to pause, take a breath, and reflect on all that we have accomplished this …

Become a Member

OMPRN connects pathologists and molecular pathology researchers across Ontario. Become a member to access exclusive research, educational and networking resources.

Join OMPRN

OMPRN’s patient resources

OMPRN aims to meet the education needs of everyone, from budding researchers to patients and members of the greater patient community.

View all Patient Resources

OMPRN was established by the Ontario Institute for Cancer Research (OICR) as part of its 2016-2021 Strategic Plan. OMPRN is also part of OICR’s Adaptive Oncology (AO) Initiative.